At a glance
- Originator Sankyo
- Class Antibacterials
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 21 May 2001 Profile reviewed but no significant changes made
- 21 Jun 1995 No-Development-Reported for Bacterial infections in Japan (Unknown route)
- 13 Jun 1995 New profile